Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis

Most breast cancers express the estrogen receptor (ER), but the immune response of hormone receptor-positive (HR+) breast cancer remains poorly characterized. Here, dendritic cells loaded with tumor lysate are used to identify tumor-reactive CD8 T cells, which are detected in most HR+ breast cancer...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cell reports. Medicine Ročník 6; číslo 8; s. 102252
Hlavní autoři:	Pinho, Mariana Pereira, Antoun, Elie, Sandhar, Balraj, Shu, Ting, Gao, Fei, Yang, Xiaobao, Bates, Adam, Cerundolo, Lucia, Hamid, Megat H.B.A., Maldonado-Perez, David, Teague, Renuka, Warner, Eve, Winter, Lucinda, Alham, Nasullah Khalid, Verrill, Clare, Lord, Simon R., Rostron, Timothy, Clark, Sally-Ann, Waugh, Craig, Sopp, Paul, Conlon, Chris, Fernandes, Ricardo A., Harris, Adrian L., Peng, Yanchun, Adwani, Asha, Dong, Tao
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 19.08.2025 Elsevier
Témata:	Advanced Basic Science antitumor CD8 T cells Breast Neoplasms - immunology Breast Neoplasms - pathology cancer testis antigen CD8-Positive T-Lymphocytes - immunology CDR3 CTA Dendritic Cells - immunology ER+ breast cancer Female Humans Lymph Nodes - pathology Lymphatic Metastasis - immunology Lymphocytes, Tumor-Infiltrating - immunology metastatic luminal breast cancer Middle Aged moDC Receptors, Antigen, T-Cell - immunology Receptors, Antigen, T-Cell - metabolism Receptors, Estrogen - metabolism T cell receptor T cell repertoire tumor lysate tumor-specific T cells tumor lysate ER+ breast cancer CTA moDC T cell receptor T cell repertoire metastatic luminal breast cancer tumor-specific T cells antitumor CD8 T cells CDR3 cancer testis antigen
ISSN:	2666-3791, 2666-3791
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!